3.93 USD
+1.62 (+70.13%)
3.45 USD
-0.48 (-12.21%)
ChartMill assigns a Buy % Consensus number of 83% to NEXI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is -48.09% below the current price.
NEXI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NEXI.
In the previous month the buy percentage consensus was at a similar level.
NEXI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-16 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-11-15 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-08-16 | Barclays | Maintains | Overweight |
| 2022-08-16 | Raymond James | Maintains | Outperform |
| 2022-06-01 | BTIG | Initiate | Buy |
| 2022-02-22 | Raymond James | Maintains | Outperform |
| 2021-11-15 | Raymond James | Maintains | Outperform |
| 2021-04-01 | Raymond James | Initiate | Outperform |
| 2021-03-09 | Cantor Fitzgerald | Initiate | Overweight |
NEXIMMUNE INC / NEXI FAQ
What is the price target for NEXI stock?
7 analysts have analysed NEXI and the average price target is 2.04 USD. This implies a price decrease of -48.09% is expected in the next year compared to the current price of 3.93.
What is the consensus rating for NEXIMMUNE INC (NEXI) stock?
The consensus rating for NEXIMMUNE INC (NEXI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.